Progress in surgical treatment of malignant pleural mesothelioma
10.3760/cma.j.cn112434-20211105-00353
- VernacularTitle:恶性胸膜间皮瘤治疗进展
- Author:
Bin ZHOU
1
;
Linlin QIN
;
Zhao LI
;
Kaiqi JIN
;
Yuming ZHU
;
Gening JIANG
;
Jie DAI
Author Information
1. 同济大学附属上海市肺科医院胸外科，上海 200433
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2023;39(1):51-57
- CountryChina
- Language:Chinese
-
Abstract:
Malignant pleural mesothelioma(MPM) is a kind of rare and aggressive malignant neoplasm. Surgery plays one of the most important roles in the treatment of MPM. However, due to the high morbidity and mortality reported, the survival benefit and indication of surgery are still controversial. This article will review the surgical indications, discuss and compare the roles of extrapleural pneumonectomy(EPP) and pleurectomy / decortication(P/D) which aim to achieve macroscopic complete resection(MCR) in the treatment of MPM. Finally, we summarized the progress of other treatment methods including targeted therapy and immunotherapy.
